Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00447694
First received: March 13, 2007
Last updated: April 25, 2012
Last verified: April 2012